Home » Poll Results » September 2022 Question of the Month

September 2022 Question of the Month

Which medical condition will benefit the most from digital therapeutics?

ADHD: 0%

Behavior and Mental Health: 62.5%

Diabetes: 25%

Gastrointestinal: 0%

Genitourinary: 0%

Musculoskeletal: 0%

Sleep: 0%

Substance Use Disorder: 0%

Wellness: 12.5%

Other: 0%

November 2023 Question of the Month

CVS announced voluntary removal of some phenylephrine products from shelves. How will competing pharmacies react?

Slowly follow phenylephrine removal: 40.0%

No action – wait for FDA decision: 46.7%

Pharmacies will trim low selling inventory: 13.3%

Pharmacies will increase inventory to capture sales: 0%

What is the greatest challenge for prescription digital therapeutics?

Payer coverage: 57%

Provider willingness to prescribe: 14%

Patient acceptance of use: 0%

Distribution outside normal channels: 29%

How will Artificial Intelligence tools impact health care in 2024?

Drastic increase health provider productivity: 0%

Selective use cases and minor positive impact: 66.6%

Negative impact due to errors: 16.7%

No uptake and impact: 16.7%